Sanjivani Paranterals Ltd (BOM:531569)

Q2 2026 Sanjivani Paranteral Ltd Earnings Call Transcript

Nov 18, 2025 / 05:30 AM GMT

Release Date Price: ₹187.25 (+2.97%)

Transcript

Key Points

Positve

Sanjivani Paranterals Ltd (BOM:531569) has a strong presence in over 25 countries, focusing on life-saving drugs, which positions it well in the global market.
The company is expanding its business through three verticals: Sanjivani Paranterals Ltd, SPL Infusion, and Olivia Healthcare, which diversifies its revenue streams.
Despite external disruptions, the company remains optimistic about achieving a 10% growth in the upcoming quarters.
The company has started commercial production at its Pune plant, which is expected to contribute significantly to revenue in the coming quarters.
Sanjivani Paranterals Ltd is actively participating in trade shows to boost revenue momentum and has a healthy order book for its new ventures.

Negative

The company reported a 14.5% year-on-year decline in revenue for Q2 FY26, primarily due to external disruptions in key export markets.
EBITDA declined by 25.6% year-on-year, with margins contracting from 17.9% to 15.5%, reflecting lower profitability.
Prolonged local unrest in Nepal and tighter FDA scrutiny in Latin America have delayed shipments and impacted revenue.
The antibiotic market is declining due to resistance issues, affecting a segment of the company's business.
Regulatory challenges in Latin America and other markets may continue to pose risks to the company's growth and compliance costs.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SANJ.BO - Sanjivani Paranteral Ltd
Q2 2026 Sanjivani Paranteral Ltd Earnings Call
Nov 19, 2025 / 05:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to Sanjeevani Parental Limited Q2 F526 earnings conference call. From the Sanjeevni management we have with us Mr. Ashwani Kemka, Chairman and managing director, Mr. Shrivardan Kemka, executive director, and Mr. Prash Chain, Chief Financial Officer. We will begin with management commentary, after which we will open the floor for questions. As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing 0 on his touchtone phone. Please note that this conference is being recorded. I now hand the

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.